UN-backed agency secures sub-licensing deals for generic Roche flu drug across 129 low- and middle-income countries
An agency supported by the United Nations has finalized sub-licensing contracts with eleven drug manufacturers to create generic versions of Roche’s influenza medication Xofluza.
The agreements allow the partners to produce and distribute the generic drug in 129 nations, encompassing almost all low- and middle-income markets.
To facilitate approval, the companies will receive technical dossiers, reference product samples for bioequivalence testing, and regulatory assistance.
The initiative aims to broaden access to an important antiviral ahead of potential flu pandemics, reflecting a push to balance commercial interests with global health needs.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic”
read at STAT ↗
comments(0)
5-min edit window · permanent after that